BREAKING NEWS

U.S. health regulator approves Teva's migraine drug

By REUTERS

SEPTEMBER 15, 2018 01:29

Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine treatment, a key drug the company has been banking on to help revive its fortunes.

The world's largest generic drugmaker had hoped to receive approval for the injectable drug, fremanezumab, by June. Its release was delayed due to U.S. regulatory concerns about the manufacturing process at the South Korean plant of its development partner Celltrion.

Around 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation, making for a large market that has attracted several drugmakers.

'Shalom Hamas means Hello and Goodbye - You can choose': Trump

By JERUSALEM POST STAFF

03/05/2025 11:56 PM

US Justice Department opens University of California antisemitism probe

By REUTERS

03/05/2025 11:51 PM

Russian missile attack kills two, injures seven in Ukraine's Kryvyi Rih

By REUTERS

03/05/2025 11:48 PM

Delegation of released hostages meets with Trump at the White House

By WALLA!

03/05/2025 11:21 PM